Last update 07 Jul 2026
Foreland Pharma Co Ltd

Foreland Pharma Co Ltd

Subsidiary Company|2011|Beijing Shi, China|
www.forelandpharma.com

Overview

Tags

Cardiovascular Diseases
Neoplasms
Endocrinology and Metabolic Disease
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Neoplasms2
Endocrinology and Metabolic Disease2
Top 5 Drug TypeCount
Small molecule drug3
Top 5 TargetCount
Protein kinases1
ATR(Serine-protein kinase ATR)1
S1PRs(Sphingosine 1-phosphate receptors)1

Related

3
Drugs associated with Foreland Pharma Co Ltd
FP-253/FP-264
Target
S1PRs
Mechanism
S1PRs agonists
Active Org.
Foreland Pharma Co LtdForeland Pharma Co Ltd
Originator Org.
Foreland Pharma Co LtdForeland Pharma Co Ltd
Active Indication-
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
WO2026130382
Patent Mining
Target
ATR
Mechanism-
Active Org.
Foreland Pharma Co LtdForeland Pharma Co Ltd
Originator Org.
Foreland Pharma Co LtdForeland Pharma Co Ltd
Active Indication
Cardiovascular Diseases [+3]
Inactive Indication-
Drug Highest PhaseDiscovery
First Approval Ctry. / Loc.-
First Approval Date-
WO2026130110
Patent Mining
Target
Protein kinases
Mechanism-
Active Org.
Foreland Pharma Co LtdForeland Pharma Co Ltd
Originator Org.
Foreland Pharma Co LtdForeland Pharma Co Ltd
Active Indication
Cardiovascular Diseases [+2]
Inactive Indication-
Drug Highest PhaseDiscovery
First Approval Ctry. / Loc.-
First Approval Date-
1
Clinical Trials associated with Foreland Pharma Co Ltd
CTR20180683
/ CompletedPhase 1
评估FP-208单药治疗晚期实体肿瘤患者的安全性、耐受性、药代动力学特征和初步疗效的开放性、剂量递增I期临床研究
[Translation] An open-label, dose-escalation Phase I clinical study to evaluate the safety, tolerability, pharmacokinetic characteristics and preliminary efficacy of FP-208 monotherapy in patients with advanced solid tumors
100 Clinical Results associated with Foreland Pharma Co Ltd
Login to view more data
0 Patents (Medical) associated with Foreland Pharma Co Ltd
Login to view more data
100 Deals associated with Foreland Pharma Co Ltd
Login to view more data
100 Translational Medicine associated with Foreland Pharma Co Ltd
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 08 Jul 2026

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Discovery
2
1
Preclinical
Other
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
WO2026130382
 ( ATR )Patent Mining		DNA Damage
More
Discovery
WO2026130110
 ( Protein kinases )Patent Mining		Cardiovascular Diseases
More
Discovery
FP-208
 ( PI3Ks x mTORC1 x mTORC2 )		Advanced Malignant Solid Neoplasm
More
Pending
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free